Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Orifice Endoscopic Surgery | 10 | 2024 | 34 | 2.050 |
Why?
|
Esophageal Achalasia | 8 | 2024 | 29 | 1.960 |
Why?
|
Heller Myotomy | 3 | 2021 | 5 | 1.040 |
Why?
|
Stomach | 3 | 2010 | 84 | 1.010 |
Why?
|
Endoscopy, Gastrointestinal | 4 | 2015 | 117 | 0.830 |
Why?
|
Colonoscopy | 2 | 2016 | 103 | 0.820 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 5 | 2016 | 50 | 0.730 |
Why?
|
Pyloromyotomy | 1 | 2021 | 6 | 0.730 |
Why?
|
Health Resources | 1 | 2021 | 88 | 0.680 |
Why?
|
Sphincterotomy, Endoscopic | 2 | 2016 | 8 | 0.670 |
Why?
|
Ascites | 1 | 2019 | 21 | 0.640 |
Why?
|
Esophageal Motility Disorders | 3 | 2023 | 10 | 0.640 |
Why?
|
Gastroscopy | 4 | 2021 | 24 | 0.640 |
Why?
|
Inpatients | 1 | 2021 | 295 | 0.590 |
Why?
|
Adenoma | 2 | 2015 | 63 | 0.590 |
Why?
|
Patient Compliance | 2 | 2016 | 371 | 0.550 |
Why?
|
Patient Readmission | 1 | 2021 | 420 | 0.530 |
Why?
|
Quality Indicators, Health Care | 2 | 2016 | 330 | 0.500 |
Why?
|
Barrett Esophagus | 1 | 2015 | 33 | 0.500 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2015 | 6 | 0.490 |
Why?
|
Ampulla of Vater | 1 | 2015 | 13 | 0.490 |
Why?
|
Precancerous Conditions | 1 | 2015 | 72 | 0.490 |
Why?
|
Myotomy | 3 | 2024 | 12 | 0.480 |
Why?
|
Liver Cirrhosis | 2 | 2014 | 160 | 0.480 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 77 | 0.470 |
Why?
|
Esophageal Sphincter, Lower | 5 | 2023 | 20 | 0.440 |
Why?
|
Life Style | 1 | 2015 | 328 | 0.440 |
Why?
|
Catheter Ablation | 1 | 2015 | 140 | 0.430 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 255 | 0.430 |
Why?
|
Surgical Instruments | 2 | 2010 | 41 | 0.420 |
Why?
|
Adenocarcinoma | 1 | 2015 | 323 | 0.410 |
Why?
|
Quality of Health Care | 2 | 2014 | 519 | 0.400 |
Why?
|
Disease Progression | 2 | 2015 | 1046 | 0.390 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2013 | 167 | 0.390 |
Why?
|
Manometry | 2 | 2024 | 22 | 0.390 |
Why?
|
Health Services Accessibility | 1 | 2016 | 541 | 0.370 |
Why?
|
Liver Neoplasms | 1 | 2013 | 277 | 0.360 |
Why?
|
Middle Aged | 16 | 2024 | 16256 | 0.360 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 317 | 0.350 |
Why?
|
Pamphlets | 1 | 2010 | 15 | 0.350 |
Why?
|
Electric Impedance | 3 | 2024 | 35 | 0.340 |
Why?
|
Suture Anchors | 1 | 2009 | 5 | 0.340 |
Why?
|
Digestive System Surgical Procedures | 1 | 2010 | 87 | 0.340 |
Why?
|
Aged | 13 | 2024 | 13340 | 0.320 |
Why?
|
Treatment Outcome | 10 | 2024 | 5174 | 0.310 |
Why?
|
Brucellosis | 1 | 2007 | 3 | 0.290 |
Why?
|
Drainage | 3 | 2016 | 145 | 0.290 |
Why?
|
Pancreatic Diseases | 1 | 2007 | 39 | 0.290 |
Why?
|
Pancreatitis, Chronic | 1 | 2007 | 22 | 0.280 |
Why?
|
Postoperative Hemorrhage | 2 | 2018 | 33 | 0.280 |
Why?
|
Male | 16 | 2024 | 27556 | 0.280 |
Why?
|
Anxiety | 1 | 2010 | 396 | 0.270 |
Why?
|
Humans | 24 | 2024 | 59454 | 0.270 |
Why?
|
Patient Education as Topic | 1 | 2010 | 446 | 0.270 |
Why?
|
Swine | 4 | 2010 | 345 | 0.260 |
Why?
|
Female | 17 | 2024 | 30893 | 0.250 |
Why?
|
Gastrostomy | 3 | 2010 | 33 | 0.250 |
Why?
|
Hemorrhage | 1 | 2007 | 268 | 0.250 |
Why?
|
Adult | 11 | 2024 | 15767 | 0.230 |
Why?
|
Retrospective Studies | 5 | 2024 | 6007 | 0.230 |
Why?
|
Postoperative Complications | 4 | 2021 | 1133 | 0.230 |
Why?
|
Esophagoscopy | 3 | 2024 | 28 | 0.220 |
Why?
|
Esophageal Spasm, Diffuse | 1 | 2022 | 3 | 0.210 |
Why?
|
Referral and Consultation | 2 | 2016 | 410 | 0.200 |
Why?
|
Argon Plasma Coagulation | 1 | 2021 | 3 | 0.190 |
Why?
|
Gastric Antral Vascular Ectasia | 1 | 2021 | 4 | 0.190 |
Why?
|
Hospital Charges | 1 | 2021 | 23 | 0.180 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 86 | 0.170 |
Why?
|
Pancreatic Pseudocyst | 2 | 2010 | 13 | 0.170 |
Why?
|
Suture Techniques | 2 | 2010 | 84 | 0.170 |
Why?
|
Length of Stay | 2 | 2021 | 768 | 0.170 |
Why?
|
Pressure | 2 | 2010 | 75 | 0.170 |
Why?
|
Intraoperative Complications | 2 | 2018 | 81 | 0.170 |
Why?
|
Stents | 2 | 2016 | 447 | 0.170 |
Why?
|
Palliative Care | 2 | 2013 | 212 | 0.160 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 2473 | 0.160 |
Why?
|
Massachusetts | 2 | 2016 | 2095 | 0.160 |
Why?
|
Risk Factors | 2 | 2021 | 5010 | 0.150 |
Why?
|
Pancreatitis | 2 | 2016 | 101 | 0.150 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 904 | 0.150 |
Why?
|
Databases, Factual | 1 | 2021 | 839 | 0.140 |
Why?
|
Insufflation | 1 | 2016 | 10 | 0.140 |
Why?
|
Retroperitoneal Space | 1 | 2016 | 21 | 0.140 |
Why?
|
Peritoneum | 1 | 2016 | 25 | 0.140 |
Why?
|
Heart Arrest | 2 | 2018 | 158 | 0.140 |
Why?
|
Emphysema | 1 | 2016 | 29 | 0.140 |
Why?
|
Bile Duct Neoplasms | 2 | 2014 | 41 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2016 | 90 | 0.130 |
Why?
|
Hospital Mortality | 1 | 2021 | 846 | 0.130 |
Why?
|
Pneumopericardium | 1 | 2015 | 3 | 0.130 |
Why?
|
Tertiary Care Centers | 1 | 2016 | 102 | 0.130 |
Why?
|
United States | 2 | 2021 | 7515 | 0.120 |
Why?
|
Risk Assessment | 2 | 2021 | 1913 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 36 | 0.120 |
Why?
|
Disease Management | 1 | 2016 | 220 | 0.120 |
Why?
|
Common Bile Duct | 1 | 2014 | 19 | 0.120 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 28 | 0.120 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 25 | 0.110 |
Why?
|
Gastroenterology | 1 | 2014 | 53 | 0.110 |
Why?
|
Endosonography | 1 | 2013 | 33 | 0.110 |
Why?
|
Esophagogastric Junction | 2 | 2023 | 15 | 0.110 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 63 | 0.110 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 392 | 0.110 |
Why?
|
Time Factors | 1 | 2021 | 3578 | 0.110 |
Why?
|
Models, Animal | 2 | 2010 | 221 | 0.100 |
Why?
|
Prospective Studies | 4 | 2018 | 3096 | 0.100 |
Why?
|
Catheterization | 2 | 2010 | 110 | 0.100 |
Why?
|
Body Mass Index | 1 | 2015 | 885 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2016 | 5098 | 0.090 |
Why?
|
Multivariate Analysis | 1 | 2013 | 925 | 0.090 |
Why?
|
Mass Screening | 1 | 2016 | 647 | 0.090 |
Why?
|
Surgical Stapling | 1 | 2010 | 11 | 0.090 |
Why?
|
Cohort Studies | 2 | 2014 | 2443 | 0.090 |
Why?
|
Smoking | 1 | 2015 | 829 | 0.090 |
Why?
|
Sutures | 1 | 2010 | 33 | 0.090 |
Why?
|
Meperidine | 1 | 2010 | 4 | 0.090 |
Why?
|
Midazolam | 1 | 2010 | 12 | 0.090 |
Why?
|
Anti-Anxiety Agents | 1 | 2010 | 31 | 0.090 |
Why?
|
Abdominal Wall | 1 | 2010 | 21 | 0.090 |
Why?
|
Narcotics | 1 | 2010 | 50 | 0.090 |
Why?
|
Transducers | 1 | 2010 | 27 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2010 | 132 | 0.080 |
Why?
|
Physicians | 1 | 2014 | 437 | 0.080 |
Why?
|
Equipment Design | 1 | 2010 | 317 | 0.080 |
Why?
|
Animals | 4 | 2010 | 19646 | 0.080 |
Why?
|
Surgical Staplers | 1 | 2008 | 6 | 0.080 |
Why?
|
Cholestasis | 1 | 2009 | 52 | 0.080 |
Why?
|
Survival Rate | 1 | 2010 | 790 | 0.080 |
Why?
|
Follow-Up Studies | 1 | 2013 | 2327 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 215 | 0.070 |
Why?
|
Hospitalization | 1 | 2014 | 1283 | 0.070 |
Why?
|
Pilot Projects | 1 | 2010 | 922 | 0.070 |
Why?
|
Brunner Glands | 1 | 2007 | 2 | 0.070 |
Why?
|
Cysts | 1 | 2007 | 37 | 0.070 |
Why?
|
Patient Selection | 2 | 2018 | 447 | 0.050 |
Why?
|
Ligation | 1 | 2021 | 35 | 0.050 |
Why?
|
Hematocrit | 1 | 2021 | 32 | 0.050 |
Why?
|
Postoperative Care | 1 | 2021 | 112 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2021 | 147 | 0.040 |
Why?
|
Alloys | 2 | 2010 | 28 | 0.040 |
Why?
|
Operative Time | 1 | 2018 | 63 | 0.040 |
Why?
|
Symptom Assessment | 1 | 2018 | 39 | 0.040 |
Why?
|
Treatment Failure | 1 | 2018 | 188 | 0.040 |
Why?
|
Preoperative Care | 1 | 2018 | 176 | 0.040 |
Why?
|
Recurrence | 1 | 2018 | 577 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2018 | 1448 | 0.030 |
Why?
|
Ultrasonography | 1 | 2014 | 453 | 0.020 |
Why?
|
Viscera | 1 | 2010 | 11 | 0.020 |
Why?
|
Cholelithiasis | 1 | 2010 | 21 | 0.020 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2010 | 46 | 0.020 |
Why?
|
Stainless Steel | 1 | 2009 | 15 | 0.020 |
Why?
|
Terminally Ill | 1 | 2009 | 17 | 0.020 |
Why?
|
International Cooperation | 1 | 2009 | 81 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2009 | 70 | 0.020 |
Why?
|
Probability | 1 | 2009 | 172 | 0.020 |
Why?
|
Mouth | 1 | 2008 | 32 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2009 | 206 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2008 | 97 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 387 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2009 | 454 | 0.020 |
Why?
|
Survival Analysis | 1 | 2009 | 553 | 0.020 |
Why?
|
Intestinal Polyps | 1 | 2007 | 7 | 0.020 |
Why?
|
Gastritis | 1 | 2007 | 17 | 0.020 |
Why?
|
Helicobacter Infections | 1 | 2007 | 55 | 0.020 |
Why?
|
Laparoscopy | 1 | 2010 | 387 | 0.020 |
Why?
|
Prognosis | 1 | 2009 | 1572 | 0.010 |
Why?
|
Quality of Life | 1 | 2009 | 1118 | 0.010 |
Why?
|